| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 656746 | 05310002 | FOSAVANCE 70 MG/2.800 UI COMPRIMIDOS | FOSAVANCE 70 MG/2.800 UI COMPRIMIDOS , 4 comprimidos | 70 mg/2.800 UI | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/05310002/05310002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/05310002/05310002_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48716 | 35083 | 2005-09-05 | 1 | 1 | 1 | 2005-09-05 | 2007-12-21 | 1 | 2011-03-21 | 651606 | View Edit Delete | |||||||||||
| 658667 | 06364002 | ADROVANCE 70 MG/2.800 UI COMPRIMIDOS | ADROVANCE 70 MG/2.800 UI COMPRIMIDOS , 4 comprimidos | 70 mg/2.800 UI | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06364002/06364002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06364002/06364002_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48716 | 35083 | 2007-03-05 | 1 | 1 | 1 | 2007-03-05 | 2007-03-05 | 1 | 2011-03-21 | View Edit Delete | ||||||||||||
| 660088 | 05310007 | FOSAVANCE 70 MG/5.600 UI COMPRIMIDOS | FOSAVANCE 70 MG/5.600 UI COMPRIMIDOS , 4 comprimidos | 70 mg/5.600 UI | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/05310007/05310007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/05310007/05310007_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48716 | 35083 | 2007-11-23 | 1 | 1 | 1 | 2007-11-23 | 2007-11-23 | 1 | 2011-03-21 | View Edit Delete | ||||||||||||
| 660438 | 06364007 | ADROVANCE 70 MG/5.600 UI COMPRIMIDOS | ADROVANCE 70 MG/5.600 UI COMPRIMIDOS , 4 comprimidos | 70 mg/5.600 UI | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06364007/06364007_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06364007/06364007_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48716 | 35083 | 2008-02-05 | 1 | 1 | 1 | 2008-02-05 | 2008-02-05 | 1 | 2011-03-21 | View Edit Delete | ||||||||||||
| 661126 | 05310002IP | FOSAVANCE 70 mg/2.800 UI COMPRIMIDOS | FOSAVANCE 70 mg/2.800 UI COMPRIMIDOS, 4 comprimidos | 70 mg/2.800 UI | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/05310002IP/05310002IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/05310002IP/05310002IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28082 | 18672 | 2008-11-27 | 1 | 1 | 1 | 2008-11-27 | 2008-11-27 | 1 | 2019-12-04 | View Edit Delete | ||||||||||||
| 687665 | 60612 | LOGIMAX 5 MG/50 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA | LOGIMAX 5 MG/50 MG COMPRIMIDOS DE LIBERACIÓN PROLONGADA , 30 comprimidos | 50 mg/5 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60612/60612_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60612/60612_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2359 | 15657 | 1996-12-01 | 1 | 1 | 1 | 1996-12-01 | 1996-12-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 708780 | 05310007IP | FOSAVANCE 70mg/5600UI comprimidos | FOSAVANCE 70mg/5600UI comprimidos 4 comprimidos | 70 mg/5.600 UI | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/05310007IP/05310007IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/05310007IP/05310007IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28082 | 18672 | 2015-11-20 | 1 | 1 | 1 | 2015-11-20 | 2015-11-20 | 1 | 2019-12-04 | View Edit Delete | ||||||||||||
| 731023 | 05310007IP1 | FOSAVANCE 70 MG/5.600 UI COMPRIMIDOS | FOSAVANCE 70 MG/5.600 UI COMPRIMIDOS, 4 comprimidos | 70 mg + 5.600 UI | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/05310007IP1/05310007IP1_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/05310007IP1/05310007IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34945 | 23628 | 2021-05-18 | 1 | 1 | 1 | 2021-05-19 | 2021-05-18 | 1 | 2021-06-29 | View Edit Delete | ||||||||||||
| 764526 | 05310002IP1 | FOSAVANCE 70 MG/2.800 UI COMPRIMIDOS | FOSAVANCE 70 MG/2.800 UI COMPRIMIDOS, 4 comprimidos | 70 mg/2.800 UI | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/05310002IP1/05310002IP1_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/05310002IP1/05310002IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48716 | 17193 | 2024-03-12 | 1 | 1 | 1 | 2024-03-13 | 2024-03-12 | 1 | 2024-05-22 | View Edit Delete | ||||||||||||
| 764527 | 05310007IP2 | FOSAVANCE 70 MG/5.600 UI COMPRIMIDOS | FOSAVANCE 70 MG/5.600 UI COMPRIMIDOS, 4 comprimidos | 70 mg/5.600 UI | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/05310007IP2/05310007IP2_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/05310007IP2/05310007IP2_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48716 | 17193 | 2024-03-12 | 1 | 1 | 1 | 2024-03-13 | 2024-03-12 | 1 | 2024-05-22 | View Edit Delete | ||||||||||||
| 764701 | 05310002IP2 | FOSAVANCE 70 MG/2.800 UI COMPRIMIDOS | FOSAVANCE 70 MG/2.800 UI COMPRIMIDOS, 4 comprimidos | 70 mg/2.800 UI | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/05310002IP2/05310002IP2_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/05310002IP2/05310002IP2_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48716 | 23628 | 2024-04-10 | 1 | 1 | 1 | 2024-04-11 | 2024-04-10 | 1 | 2024-07-18 | View Edit Delete | ||||||||||||
| 765163 | 05310007IP3 | FOSAVANCE 70 MG/5.600 UI COMPRIMIDOS | FOSAVANCE 70 MG/5.600 UI COMPRIMIDOS, 4 comprimidos | 70 mg/5.600 UI | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/05310007IP3/05310007IP3_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/05310007IP3/05310007IP3_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48716 | 41972 | 2024-06-18 | 1 | 1 | 1 | 2024-06-19 | 2024-06-18 | 1 | 2024-09-19 | View Edit Delete | ||||||||||||
| 765350 | 06364007IP | ADROVANCE 70 MG/5.600 UI COMPRIMIDOS | ADROVANCE 70 MG/5.600 UI COMPRIMIDOS, 4 comprimidos | 70 mg/5.600 UI | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06364007IP/06364007IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06364007IP/06364007IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48716 | 17193 | 2024-07-12 | 1 | 1 | 1 | 2024-07-13 | 2024-07-12 | 1 | 2025-04-23 | View Edit Delete | ||||||||||||
| 765581 | 05310007IP4 | FOSAVANCE 70 MG/5.600 UI COMPRIMIDOS | FOSAVANCE 70 MG/5.600 UI COMPRIMIDOS, 4 comprimidos | 70 mg/5.600 UI | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/05310007IP4/05310007IP4_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/05310007IP4/05310007IP4_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48716 | 37912 | 2024-08-16 | 1 | 1 | 1 | 2024-08-17 | 2024-08-16 | 1 | 2024-10-01 | View Edit Delete | ||||||||||||
| 767547 | 06364007IP1 | ADROVANCE 70 MG/5.600 UI COMPRIMIDOS | ADROVANCE 70 MG/5.600 UI COMPRIMIDOS, 4 comprimidos | 70 mg/5.600 UI | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06364007IP1/06364007IP1_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06364007IP1/06364007IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48716 | 23628 | 2025-05-06 | 1 | 1 | 1 | 2025-05-07 | 2025-05-06 | 1 | 2025-08-13 | View Edit Delete | ||||||||||||
| 820571 | 62760 | TRIAPIN 5 mg/5 mg COMPRIMIDOS DE LIBERACION PROLONGADA | TRIAPIN 5 mg/5 mg COMPRIMIDOS DE LIBERACION PROLONGADA , 28 comprimidos | 5 mg/5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62760/62760_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62760/62760_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40842 | 40842 | 1999-10-01 | 1 | 1 | 1 | 1999-10-01 | 1999-10-01 | 1 | 2011-06-09 | View Edit Delete | ||||||||||||
| 891416 | 59269 | PLENDIL 5 mg COMPRIMIDOS DE LIBERACION PROLONGADA | PLENDIL 5 mg COMPRIMIDOS DE LIBERACION PROLONGADA, 30 comprimidos | 5 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59269/59269_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59269/59269_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 34623 | 34623 | 1993-02-01 | 1 | 1 | 1 | 1993-02-01 | 1993-02-01 | 1 | 2011-10-21 | View Edit Delete |